Compare Stocks: TIL vs. ALGS vs. IMA vs. CRVO
Compare normalized stock price performance over 6 months, 1 year or 2 years. Each line starts at 0%, so different stock prices can be compared on the same scale.
TILALGSIMACRVO
Market Snapshot
Current market context for the selected companies.
TIL
$7.88
Market Cap
$53.10M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-26
ALGS
$7.46
Market Cap
$46.90M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-26
IMA
$5.43
Market Cap
$61.76M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-26
CRVO
$2.65
Market Cap
$40.07M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-26
Performance
Absolute returns and relative performance versus SPY.
| Metric | TIL | ALGS | IMA | CRVO |
|---|---|---|---|---|
| 1 Month | +8.1% | +75.5% | -5.7% | +3.7% |
| 1 Month vs SPY | +4.8% | +72.2% | -9.1% | +0.4% |
| 3 Months | -3.2% | +33.2% | -8.4% | -12.7% |
| 3 Months vs SPY | -5.2% | +31.2% | -10.4% | -14.7% |
| 6 Months | -7.8% | +7.5% | -19.2% | -39.5% |
| 6 Months vs SPY | -18.3% | -2.9% | -29.6% | -50.0% |
| 1 Year | -69.4% | -26.9% | -61.6% | -71.8% |
| 1 Year vs SPY | -88.5% | -46.1% | -80.8% | -91.0% |
| 2 Years | -34.3% | -45.7% | -73.8% | -83.6% |
| 2 Years vs SPY | -70.9% | -82.3% | -110.4% | -120.1% |
Growth & Profitability
Operating growth, margins and capital efficiency.
Valuation
Common valuation multiples shown side by side.
Cash Flow & Balance Sheet
Cash generation and leverage context.
Earnings Outlook
Upcoming earnings expectations when available.